Public Relations


"Starting with our proprietary positioning and messaging methodology – LHS Immersion® – we partner with clients to develop integrated communications’ programs that build influence and awareness and reach the right stakeholders, with the right messages at the right time."

--Sharon Correia

Our Public Relations services help our clients educate target audiences about their unique value proposition through corporate and product story development. We build influence and awareness to position our clients and/or their products as the right choice for critical stakeholders.
We provide:

Douglas Russell

Senior Vice President & General Manager

Phone: 617-374-8800 x108
Email: drussell@lavoiehealthscience.com

Sharon Correia

Senior Vice President, Integrated Communications

Phone: 617-374-8800 x105
Email: scorreia@lavoiehealthscience.com

Bell Ringer Merit Award 2016

PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations. The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

@LaVoieGroup

- 2 days ago

RT @sirionbiotechmu: SIRION Biotech's Francois Vromman comments on what's happening in one of the world's pioneering countries for #cellthe…
@LaVoieGroup

- 2 days ago

"Recruiting and retaining trial participants is now the greatest obstacle, other than funding, to developing the ne… https://t.co/kU34XZTplE
@LaVoieGroup

- 3 days ago

Today is #TheLongestDay and the @alzassociation is bringing communities together to #endalz. Check out their galler… https://t.co/F0K1h5Z3C1
@LaVoieGroup

- 3 days ago

Learn more about @AC_Immune_SA CEO Andrea Pfeifer's ambition to find a cure for #Alzheimers in this #WOW podcast… https://t.co/Yj7YrO58Yw

Example of Public Relations: Panel Development

PAIN: a Conversation brought together industry leaders to participate in a discussion about opioid addition and the need for alternatives. This panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals.